Paul W. Schaffer - 25 May 2021 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role: Director
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol: PBLA
Transactions as of: 25 May 2021
Net transactions value: $0
Form type: 4
Filing time: 27 May 2021, 20:49:50 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBLA	Common Stock	Award	$0	+4,316	+2.7%	$0.000000	166,671	25 May 2021	Direct	F1
holding	PBLA	Common Stock						30,665	25 May 2021	By Paul W. Schaffer Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBLA	Stock Option (right to buy)	Award	$0	+12,368		$0.000000	12,368	25 May 2021	Common Stock	12,368	$4.17	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 60 shares of common stock found to be held by the reporting person as a result of a reconciliation of Issuer records.
F2	Scheduled to vest and become exercisable in four equal increments on August 25, 2021, November 24, 2021, February 25, 2022 and the earlier of May 31, 2022 and the day before the company's annual meeting of stockholders to be held in 2022.